• Molecular NameSemaxanib
  • SynonymNA
  • Weight224.307
  • Drugbank_IDN/A
  • ACS_NO194413-58-6
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)4.26
  • pkaN/A
  • LogD (pH=7, predicted)4.26
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-3.3
  • LogSw (predicted, AB/LogsW2.0)0.03
  • Sw (mg/ml) (predicted, ACD/Labs)0.11
  • No.of HBond Donors2
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds1
  • TPSA27.82
  • StatusN/A
  • AdministrationN/A
  • PharmacologyA drug intended for use in the treatment of cancer. It is still at an experimental stage and as such has not yet received a licence for use on human patients (except in the setting of a clinical trial).
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding96.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A